GlassScriptPhysician profile
Caitlin Fredericka
NPI 1457842197
$1,012.60
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $922 · 2022: $90.47.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $500.61 | 2021-2022 | |
| Journey Medical Corporation | $124.67 | 2021 | |
| Novartis Pharmaceuticals Corporation | $111.79 | 2021-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $85.76 | 2021 | |
| Vyne Pharmaceuticals INC. | $36.42 | 2021 | |
| Pfizer INC. | $35.68 | 2021 | |
| Janssen Biotech, INC. | $34.60 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $34.59 | 2021 | |
| Allergan, INC. | $25.96 | 2021 | |
| Almirall LLC | $22.52 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caitlin Fredericka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.